Human Immunodeficiency Virus (HIV)
Information about activities and policies related to HIV
FDA approved changes to the DOVATO (dolutegravir/lamivudine) product labeling to include a new indication and provide longer term safety and efficacy data
Get the latest update in HIV news
More HIV News
Sub-Topic Paragraphs
NAVIGATE THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) SECTION
![3D illustration of the HIV virus](https://public4.pagefreezer.com:443/content/FDA/28-01-2022T11:16/https://www.fda.gov/files/styles/medium_3/public/Drugs-Img-Drug-Information-Class-HIV-Overview-HIV-Virus-1600x900.png?itok=uEzuWvu_)
About HIV and the Center for Drug Evaluation and Research's role
Learn what HIV is and how CDER is working to prevent and treat HIV infections
![Family on couch with the young girl rubbing her pregnant mother's belly](https://public4.pagefreezer.com:443/content/FDA/28-01-2022T11:16/https://www.fda.gov/files/styles/medium_3/public/Drugs-Img-Drug-Information-Class-HIV-Treatment-Expecting-Family-1600x900.png?itok=-Qjn9IwH)
HIV Treatment
Get information about drugs approved to treat HIV
![Person using laptop with email graphics floating around](https://public4.pagefreezer.com:443/content/FDA/28-01-2022T11:16/https://www.fda.gov/files/styles/medium_3/public/Drugs-Img-Drug-Information-Class-HIV-Subscribe-Laptop-Email-1600x900_0.png?itok=xOzskA-w)
Subscribe to Learn What’s New in HIV at CDER
Get regular FDA email updates on HIV delivered to your inbox